Does Anaplasma phagocytophilum infect neutrophils and provoke systemic cytokine-driven inflammation?

Anaplasma phagocytophilum, the cause of human granulocytic anaplasmosis (HGA), is a neutrophil-tropic intracellular bacterium. The central claim is supported: infection of neutrophils is directly demonstrated, and systemic cytokine-mediated inflammation can occur, particularly in severe illness.

Cellular and mechanistic evidence

• Human peripheral-blood smears can show intracellular morulae within neutrophils, providing direct clinical evidence of neutrophil infection. Detection is variable (approximately 25–75% of smears); in one PCR-confirmed series, morulae were identified in 5/15 examined smears.
• In primary human neutrophils ex vivo, organisms replicate within membrane-bound morulae, with growth reported by about 24 hours. Dense-cored infectious forms convert to replicative reticulate forms and subsequently mature again.
• The organism protects this intracellular niche by inhibiting vacuole–lysosome fusion. It also delays infected-neutrophil apoptosis for roughly 48–96 hours; the Ats-1 effector contributes to this survival effect through mitochondrial targeting. These processes plausibly extend the time available for replication in normally short-lived cells.

Systemic inflammation and clinical relevance

• Acute HGA is associated with circulating IFN-γ and IL-10, consistent with concurrent inflammatory and counter-regulatory immune signaling. Severe disease can include acute respiratory distress syndrome, renal failure, and multiorgan dysfunction.
• Infected neutrophils can produce IL-8, while monocytes/peripheral blood leukocytes can produce IL-1β, TNF-α, and IL-6. Thus, inflammation reflects multicellular, partially dysregulated host responses rather than neutrophil infection alone.
• A single universal cytokine pattern is not established: one patient-serum study did not find elevated TNF-α or IL-1β, and IL-6 was not reported as elevated.

Bottom line

• A. phagocytophilum clearly infects and replicates within neutrophils and can drive clinically important systemic cytokine-associated inflammation, although the circulating cytokine signature and its relationship to severity vary across patients.